Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Pea15

  • Joanna E. Gawecka
  • Joe W. Ramos
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_212

Synonyms

Historical Background

Phosphoprotein enriched in astrocytes 15 kDa (PEA-15), also known as PED-15, is a 15 kDa protein that is highly expressed in the nervous system with particularly high levels in astrocytes and neurons of the hippocampus. Chneiweiss and colleagues first characterized PEA-15 as a major substrate for Protein Kinase C (PKC) in astrocytes and later cloned the cDNA encoding the protein (Araujo et al. 1993; Estelles et al. 1996). The first indications of the functional significance of PEA-15 was identified when it was shown to be a phosphoprotein overexpressed in skeletal muscle in patients with type 2 diabetes (Condorelli et al. 1998). In this context, PEA-15 was shown to inhibit insulin-stimulated glucose transport, indicating it may be involved in the development of type 2 diabetes. PEA-15...

This is a preview of subscription content, log in to check access.

References

  1. Araujo H, Danziger N, Cordier J, Glowinski J, Chneiweiss H. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem. 1993;268(8):5911–20.PubMedPubMedCentralGoogle Scholar
  2. Bartholomeusz C, Itamochi H, Nitta M, Saya H, Ginsberg MH, Ueno NT. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15. Oncogene. 2006;25(1):79–90.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Böck BC, Tagscherer KE, Fassl A, Krämer A, Oehme I, Zentgraf HW, et al. The PEA-15 protein regulates autophagy via activation of JNK. J Biol Chem. 2010. doi:10.1074/jbc.M109.096628.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F, et al. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 1998;17(14):3858–66.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalo P, Oriente F, et al. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene. 1999;18(31):4409–15.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Estelles A, Yokoyama M, Nothias F, Vincent JD, Glowinski J, Vernier P, et al. The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem. 1996;271(25):14800–6.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Fiory F, Formisano P, Perruolo G, Beguinot F. Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab. 2009;297(3):E592–601.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B, et al. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell. 2001;1(2):239–50.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Gawecka JE, Geerts D, Koster J, Caliva MJ, Sulzmaier FJ, Opoku-Ansah J, et al. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer. 2012;131:1556–68. doi:10.1002/ijc.27415.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Glading A, Koziol JA, Krueger J, Ginsberg MH. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res. 2007;67(4):1536–44.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Greig FH, Nixon GF. Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther. 2014;143:265–74. doi:10.1016/j.pharmthera.2014.03.006.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Kerbrat S, Vingert B, Junier MP, Castellano F, Renault-Mihara F, Dos Reis TS, et al. Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo. PLoS One. 2015;10:e0136885. doi:10.1371/journal.pone.0136885.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B, et al. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci. 1999;19(19):8244–51.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Mace PD, Wallez Y, Egger MF, Dobaczewska MK, Robinson H, Pasquale EB, et al. Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat Commun. 2013;4:1681. doi:10.1038/ncomms2687.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Mergenthaler P, Kahl A, Kamitz A, van Laak V, Stohlmann K, Thomsen S, et al. Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state. Proc Natl Acad Sci U S A. 2012;109:1518–23. doi:10.1073/pnas.1108225109.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Nagarajan A, Dogra SK, Liu AY, Green MR, Wajapeyee N. PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. Mol Cell Biol. 2014;34:2264–82. doi:10.1128/MCB.01542-13.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Pastorino S, Renganathan H, Caliva MJ, Filbert EL, Opoku-Ansah J, Sulzmaier FJ, et al. The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. FASEB J. 2010;24(8):2818–28.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Ramos JW, Kojima TK, Hughes PE, Fenczik CA, Ginsberg MH. The death effector domain of PEA-15 is involved in its regulation of integrin activation. J Biol Chem. 1998;273(51):33897–900.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Ramos JW, Townsend DA, Piarulli D, Kolata S, Light K, Hale G, et al. Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities. BMC Neurosci. 2009;10:134.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Renault-Mihara F, Beuvon F, Iturrioz X, Canton B, De BS, Leonard N, et al. Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell. 2006;17(12):5141–52.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Sulzmaier F, Opoku-Ansah J, Ramos JW. Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases. 2012;3:173–7. doi:10.4161/sgtp.20021.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci U S A. 2007;104(50):19837–42.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Valmiki MG, Ramos JW. Death effector domain-containing proteins. Cell Mol Life Sci. 2009;66(5):814–30.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Watanabe Y, Yamasaki F, Kajiwara Y, Saito T, Nishimoto T, Bartholomeusz C, et al. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis. J Neuro-Oncol. 2010;100(3):449–57.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.University of Hawaii Cancer Center, University of Hawaii at ManoaHonoluluUSA